Actively Recruiting
Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments
Led by Sunnybrook Health Sciences Centre · Updated on 2026-03-16
40
Participants Needed
1
Research Sites
173 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Over 500 million people have been infected with COVID-19, and to date, more than 6 million people have died. Many individuals who have recovered from COVID-19 continue to experience symptoms even after they have been "cured" of the disease. This condition is known as post COVID-19 condition, which can have serious health consequences. A common symptom among these individuals is chronic fatigue, characterized by persistent tiredness or lack of energy. This study aims to explore a novel treatment for symptoms of post COVID-19 condition, known as hyperbaric oxygen therapy. This approach has shown promise in helping people with post COVID-19 conditions and treating some other causes of fatigue. Hyperbaric oxygen therapy involves placing patients in a small chamber where they receive high oxygen gas levels. However, this treatment is expensive and time-consuming, and it is unclear if this treatment can be effectively assessed in a large-scale research study. This small study will help us decide if conducting a large research study is feasible. The investigators aim to assess if hyperbaric oxygen therapy can improve symptoms of post COVID-19 condition, such as fatigue.
CONDITIONS
Official Title
Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Official diagnosis of post COVID-19 condition by a healthcare practitioner
- At least 3 months since SARS-CoV-2 infection
- Persistent symptoms lasting more than 12 weeks including chronic fatigue plus one of the following: difficulty thinking or problem solving ('brain fog'), stress, or anxiety
You will not qualify if you...
- Medical conditions preventing safe hyperbaric treatment (e.g., pneumothorax, active unstable coronary disease)
- Cognitive difficulties or mental retardation before COVID diagnosis
- History of traumatic brain injury
- Unlikely to comply with follow-up assessments (e.g., no fixed address, plans to move away)
- Known pregnancy or planning pregnancy in women of childbearing age
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N3M5
Actively Recruiting
Research Team
F
Fahad Alam, MD
CONTACT
L
Lilia Kaustov, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here